Company: EHSI
Filing Date: 2025-09-02
Form Type: PRE 14A
Source: 0001437749-25-028137
Chunk: 23

Company: Elite Health Systems Inc.
Filing Date: 2025-09-02
Form: PRE 14A
Chunk 23
---
 Company’s knowledge, all reporting persons complied with all applicable filing requirements of Section 16(a) of the Exchange Act, other than Dr. Policherla who received SEC filing codes too late to file timely.

CODE OF ETHICS

The Company has adopted a Code of Ethics (as defined in Item 406 of Regulation S-K) that applies to its principal executive, financial and accounting officers. The Company will provide a copy of its code of ethics, without charge, to any investor who requests it. Requests should be addressed in writing to Mr. Ken Minor, Secretary, 1131 W. 6 Street Suite 225, Ontario, CA 91762.

<div align='center'>13</div>

HEDGING POLICY

Our insider trading policy our directors and employees, including our executive officers, from engaging in any short sale of the Company’s securities or any purchase or sale of put or call options involving the Company’s securities. All transactions in our securities by our directors and employees, including our executive officers, must be pre-cleared with our Insider Trading Compliance Officer (currently the Chief Financial Officer) under our insider trading policy.

DIRECTOR COMPENSATION

Through March 31, 2023, our directors, who are not officers or employees, were paid a monthly retainer of $3,000. Monthly payments were reduced to $2,000 beginning in April 2023. Mr. Leimkuhler received aggregate cash payments of $31,000 in 2023. During 2023, Mr. St. Lawrence received aggregate cash payments of $12,000 and a grant of 50,000 shares of the Company’s common stock, which had a per share fair market value of approximately $4,500 at the time of grant. Mr. Merriman declined compensation for serving as a director during 2023. Directors of the Company who are officers or employees do not receive any additional compensation for serving on the Board. In January 2025 the Board issued 75,000 restricted shares to each of Messrs. St. Lawrence and Leimkuhler in lieu of cash compensation for the year ended December 2024 and each of them were issued 40,000 restricted shares in lieu of cash compensation for services during 2024. Similarly, in lieu of cash compensation, the Board issued Dr. Jeereddi 250,000 shares of common stock in consideration for his services as Chief Executive Officer and Chairman of the Board for the year ended December 31,2024 and